Chevy Chase Trust Holdings, Inc. Gilead Sciences, Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

$33.7 Billion
Q2 2025

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 662,803 shares of GILD stock, worth $75.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

662,803

Previous 659,363 0.52%

Holding current value

$75.7 Million

Previous $73.9 Million 0.54%

% of portfolio

0.22%

Previous 0.24%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$96.91 - $113.0 $333,370 - $388,720	3,440 Added 0.52%	662,803 $73.5 Million
Q1 2025 Apr 23, 2025	SELL	$89.14 - $117.41 $39,578 - $52,130	-444 Reduced 0.07%	659,363 $73.9 Million
Q4 2024 Jan 30, 2025	SELL	$83.95 - $97.9 $1.14 Million - $1.33 Million	-13,605 Reduced 2.02%	659,807 $60.9 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $810,000 - $1.02 Million	-12,164 Reduced 1.77%	673,412 $56.4 Million
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $616,280 - $711,235	-9,759 Reduced 1.4%	685,576 $47 Million
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $490,466 - $598,111	-6,852 Reduced 0.98%	695,335 $50.9 Million
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $341,071 - $386,783	-4,655 Reduced 0.66%	702,187 $56.9 Million
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $1.25 Million - $1.36 Million	-16,914 Reduced 2.34%	706,842 $53 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $553,580 - $631,436	-7,283 Reduced 1.0%	723,756 $55.8 Million
Q1 2023 May 17, 2023	BUY	$77.31 - $88.08 $54.8 Million - $62.4 Million	708,737 Added 3177.91%	731,039 $60.7 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $54.6 Million - $62.2 Million	-705,863 Reduced 96.94%	22,302 $1.85 Billion
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $2.7 Million - $3.88 Million	-43,398 Reduced 5.62%	728,165 $62.5 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $466,614 - $532,994	7,837 Added 1.03%	771,563 $47.6 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $191,399 - $215,573	3,316 Added 0.44%	763,726 $47.2 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $109,468 - $137,176	1,890 Added 0.25%	760,410 $45.2 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $1.16 Million - $1.32 Million	-17,946 Reduced 2.31%	758,520 $55.1 Million
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $2.03 Million - $2.19 Million	-30,029 Reduced 3.72%	776,466 $54.2 Million
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $2.74 Million - $2.99 Million	-43,092 Reduced 5.07%	806,495 $55.5 Million
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $3.64 Million - $4.15 Million	-60,596 Reduced 6.66%	849,587 $54.9 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $1.61 Million - $1.83 Million	-28,360 Reduced 3.02%	910,183 $53 Million
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $4.57 Million - $5.75 Million	-73,628 Reduced 7.27%	938,543 $59.3 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $4.71 Million - $5.47 Million	-65,113 Reduced 6.04%	1,012,171 $77.9 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $1.02 Million - $1.31 Million	16,359 Added 1.54%	1,077,284 $80.5 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $15,466 - $17,012	-251 Reduced 0.02%	1,060,925 $68.9 Million
Q3 2019 Nov 20, 2019	SELL	$62.51 - $69.0 $325,364 - $359,145	-5,205 Reduced 0.49%	1,061,176 $67.3 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $231,393 - $259,481	-3,740 Reduced 0.35%	1,066,381 $72 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $130,124 - $145,774	-2,081 Reduced 0.19%	1,070,121 $69.6 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $291,439 - $380,306	-4,814 Reduced 0.45%	1,072,202 $67.1 Million
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $1.98 Million - $2.19 Million	-27,759 Reduced 2.51%	1,077,016 $83.2 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $785,502 - $916,257	-12,107 Reduced 1.08%	1,104,775 $78.3 Million
Q1 2018 Apr 10, 2018	SELL	$72.84 - $88.8 $1.52 Million - $1.85 Million	-20,824 Reduced 1.83%	1,116,882 $84.2 Million
Q4 2017 Jan 22, 2018	SELL	$71.15 - $83.52 $549,847 - $645,442	-7,728 Reduced 0.67%	1,137,706 $81.5 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $82.6 Million - $97.9 Million	1,145,434	1,145,434 $92.8 Million

Others Institutions Holding GILD

# of Institutions

2,296

Shares Held

Call Options Held

9.6M

Put Options Held

10.1M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $143B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Gilead Sciences, Inc. Transaction History